Skip to main content
Premium Trial:

Request an Annual Quote

Steven Kafka

Steven Kafka has joined the board of directors of ArcherDX. He serves as a venture partner at Third Rock Ventures, and was previously the president and chief operating officer of Foundation Medicine, which is now owned by Roche. Before that, he was the COO and CFO of Aileron Therapeutics and VP of finance at Infinity Pharmaceuticals.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.